Published in Chem Commun (Camb) on March 21, 2014
Aptamer-Drug Conjugates. Bioconjug Chem (2015) 0.89
Aptamers and their applications in nanomedicine. Small (2015) 0.88
Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems. Int J Mol Sci (2015) 0.81
Design of Nanoparticle-Based Carriers for Targeted Drug Delivery. J Nanomater (2016) 0.76
Self-assembly of c-myc DNA promoted by a single enantiomer ruthenium complex as a potential nuclear targeting gene carrier. Sci Rep (2016) 0.75
Polymeric Nanoparticles of Brazilian Red Propolis Extract: Preparation, Characterization, Antioxidant and Leishmanicidal Activity. Nanoscale Res Lett (2016) 0.75
DNA Aptamer Based Nanodrugs: Molecular Engineering for Efficiency. Chem Asian J (2015) 0.75
Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment. Int J Nanomedicine (2017) 0.75
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov (2008) 12.72
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm (2005) 7.53
Biodegradable long-circulating polymeric nanospheres. Science (1994) 7.46
Drug delivery and targeting. Nature (1998) 6.16
Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A (2006) 5.35
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials (2005) 2.77
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res (2008) 2.44
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release (2002) 2.21
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A (2011) 2.16
Cell-specific internalization study of an aptamer from whole cell selection. Chemistry (2008) 1.81
Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release (2006) 1.69
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials (2011) 1.50
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials (2011) 1.36
Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir (2005) 1.32
Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano (2013) 1.31
Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res (2000) 1.29
Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A (2013) 1.29
Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir (2010) 1.14
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci U S A (2011) 1.10
Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano (2012) 1.06
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Release (2005) 1.03
Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials (2013) 1.00
One-step facile surface engineering of hydrophobic nanocrystals with designer molecular recognition. J Am Chem Soc (2012) 0.92
Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line. Biochem Pharmacol (1994) 0.92
Pharmacokinetics of combined doxorubicin and paclitaxel in mice. Cancer Lett (2005) 0.91
Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. ACS Nano (2012) 0.91
Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale (2013) 0.87
Multifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivo. Chem Commun (Camb) (2010) 0.87
Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A (2006) 5.35
Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14
Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol (2002) 3.89
Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Sci Transl Med (2011) 2.67
Development of DNA aptamers using Cell-SELEX. Nat Protoc (2010) 2.62
Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China. Emerg Infect Dis (2013) 2.61
Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem (2007) 2.57
Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res (2010) 2.48
Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res (2008) 2.44
Horizontal transfer of an adaptive chimeric photoreceptor from bryophytes to ferns. Proc Natl Acad Sci U S A (2014) 2.42
Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir (2006) 2.17
Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science (2010) 2.11
Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics (2007) 1.98
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet (2013) 1.95
Identification of liver cancer-specific aptamers using whole live cells. Anal Chem (2008) 1.90
A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci U S A (2004) 1.87
Molecular engineering of DNA: molecular beacons. Angew Chem Int Ed Engl (2009) 1.84
Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal Chem (2008) 1.84
Sleep deprivation impairs cAMP signalling in the hippocampus. Nature (2009) 1.83
Cell-specific internalization study of an aptamer from whole cell selection. Chemistry (2008) 1.81
Light-switching excimer probes for rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A (2005) 1.80
Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal Chem (2009) 1.78
Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem (2007) 1.76
Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal Chem (2005) 1.76
Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. J Am Chem Soc (2003) 1.74
Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem (2009) 1.73
GOFFA: gene ontology for functional analysis--a FDA gene ontology tool for analysis of genomic and proteomic data. BMC Bioinformatics (2006) 1.72
Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem (2008) 1.71
Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clin Chem (2007) 1.69
TRPM8 mechanism of cold allodynia after chronic nerve injury. J Neurosci (2007) 1.69
Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med (2005) 1.66
In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem (2008) 1.64
Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal Chem (2009) 1.61
Prevalence of hypertension in china: a cross-sectional study. PLoS One (2013) 1.60
Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem (2006) 1.58
DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc Natl Acad Sci U S A (2009) 1.56
Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal Chem (2007) 1.55
Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem (2008) 1.55
The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One (2011) 1.54
Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir (2004) 1.52
Locked nucleic acid molecular beacons. J Am Chem Soc (2005) 1.51
Molecular aptamer beacons for real-time protein recognition. Biochem Biophys Res Commun (2002) 1.49
Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc Natl Acad Sci U S A (2011) 1.48
Abdominal paracentesis drainage ahead of percutaneous catheter drainage benefits patients attacked by acute pancreatitis with fluid collections: a retrospective clinical cohort study. Crit Care Med (2015) 1.45
Molecular assembly for high-performance bivalent nucleic acid inhibitor. Proc Natl Acad Sci U S A (2008) 1.44
DNA-functionalized nanotube membranes with single-base mismatch selectivity. Science (2004) 1.44
Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal Chem (2012) 1.44
Carbon nanotube-quenched fluorescent oligonucleotides: probes that fluoresce upon hybridization. J Am Chem Soc (2008) 1.43
Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys. Chem Res Toxicol (2011) 1.41
Multicolor FRET silica nanoparticles by single wavelength excitation. Nano Lett (2006) 1.40
Aptamer switch probe based on intramolecular displacement. J Am Chem Soc (2008) 1.40
Bioconjugated nanoparticles for DNA protection from cleavage. J Am Chem Soc (2003) 1.39
Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int (2010) 1.38
The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol (2008) 1.38
Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir (2008) 1.37
DNA aptamers as molecular probes for colorectal cancer study. PLoS One (2010) 1.36
Uptake of silica-coated nanoparticles by HeLa cells. J Nanosci Nanotechnol (2005) 1.36
Significance analysis of groups of genes in expression profiling studies. Bioinformatics (2007) 1.36
MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol (2011) 1.34
Temperature dependence of graphene oxide reduced by hydrazine hydrate. Nanotechnology (2010) 1.33
Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano (2012) 1.32
Latent tree models and diagnosis in traditional Chinese medicine. Artif Intell Med (2007) 1.32
Generating aptamers for recognition of virus-infected cells. Clin Chem (2009) 1.31
MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS Pathog (2013) 1.29
Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A (2013) 1.29
Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. PLoS One (2010) 1.26
Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications. J Am Chem Soc (2013) 1.26
Synthetic DNA aptamers to detect protein molecular variants in a high-throughput fluorescence quenching assay. Chembiochem (2003) 1.26
Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer (2010) 1.25
Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol (2009) 1.25
Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab Chip (2013) 1.23
Regulation of singlet oxygen generation using single-walled carbon nanotubes. J Am Chem Soc (2008) 1.23
Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes. Drug Metab Dispos (2009) 1.22
Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst (2009) 1.22
Collection of trace amounts of DNA/mRNA molecules using genomagnetic nanocapturers. Anal Chem (2003) 1.21
Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem (2009) 1.20
FloDots: luminescent nanoparticles. Anal Bioanal Chem (2006) 1.20
Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol (2006) 1.20
Pyrene excimer signaling molecular beacons for probing nucleic acids. J Am Chem Soc (2007) 1.20
TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chem Commun (Camb) (2004) 1.19
DNA-based micelles: synthesis, micellar properties and size-dependent cell permeability. Chemistry (2010) 1.18
Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles. Anal Biochem (2004) 1.17
Nucleic acid aptamers for biosensors and bio-analytical applications. Analyst (2009) 1.16
An aptamer cross-linked hydrogel as a colorimetric platform for visual detection. Angew Chem Int Ed Engl (2010) 1.16
Simultaneous monitoring of the expression of multiple genes inside of single breast carcinoma cells. Anal Chem (2005) 1.16
Dual-luminophore-doped silica nanoparticles for multiplexed signaling. Nano Lett (2005) 1.15
Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine (Lond) (2012) 1.15
Molecular assembly of superquenchers in signaling molecular interactions. J Am Chem Soc (2005) 1.14
Carbon nanotubes protect DNA strands during cellular delivery. ACS Nano (2008) 1.14
Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013. Emerg Infect Dis (2013) 1.14
DNA nanoflowers for multiplexed cellular imaging and traceable targeted drug delivery. Angew Chem Int Ed Engl (2014) 1.13
Nucleic acid conjugated nanomaterials for enhanced molecular recognition. ACS Nano (2009) 1.13